Skip to main content

Table 1 Comparison of clinical characteristics between two longitudinal cohorts

From: Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudinal cohort study

Characteristics

Overall population (N=121)

P value

Cohort 1 ( N =35)

Cohort 2 ( N =86)

Baseline characteristics

Age (years)

71.7±11.4

73.6±12.3

0.418

Male, N (%)

25 (71.4)

60 (69.8)

0.856

Hypertension, N (%)

32 (91.4)

73 (84.9)

0.259

Diabetes mellitus, N (%)

20 (57.1)

37 (43.0)

0.158

Dyslipidemia, N (%)

12 (34.3)

32 (37.2)

0.762

Prior MI, N (%)

18 (51.4)

42 (48.8)

0.796

Prior stroke/TIA, N (%)

9 (25.7)

16 (18.6)

0.381

Prior heart failure, N (%)

17 (48.6)

34 (39.5)

0.361

Uremia, N (%)

7 (20.0)

17 (19.8)

0.977

Echocardiographic characteristics

LAD (mm)

46.59±7.88

44.04±8.25

0.138

LVEF (%)

49.69±14.36

51.67±16.34

0.552

AF characteristics

Paroxysmal AF, N (%)

24 (68.6)

36 (41.9)

0.008

CHA2DS2-VASc score

4.5±1.9

4.1±1.7

0.187

HAS-BLED score

3.5±1.1

3.2±1.1

0.182

  1. MI, myocardial infarction; TIA, transient ischemic attack; LAD, left atrium dimension; LVEF, left ventricular ejection fraction; AF, atrial fibrillation